Colorectal and other GI cancers:

Indications for: QINLOCK

In adults with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

Adult Dosage:

Swallow whole. 150mg once daily until disease progression or unacceptable toxicity. Concomitant moderate CYP3A4 inducer (if unavoidable): give 150mg twice daily. Dose modifications: see full labeling.

Children Dosage:

Not established.

QINLOCK Warnings/Precautions:

Risk of new primary cutaneous malignancies. Perform skin exams prior to initiation and during therapy. Manage suspicious skin lesions with excision and dermatopathologic evaluation. Uncontrolled hypertension: do not initiate. Control BP prior to initiation; monitor and treat during therapy as appropriate. Cardiac dysfunction. Assess ejection fraction by echocardiogram or MUGA scan prior to initiation, during therapy, and as clinically indicated. Permanently discontinue if Grade 3/4 left ventricular systolic dysfunction occurs. Impaired wound healing: withhold for ≥1 week prior to elective surgery; do not give for ≥2 weeks after major surgery and until adequate healing. Safety of resuming therapy after resolution of wound healing complications has not been established. Moderate or severe hepatic impairment. Severe renal impairment. Embryo-fetal toxicity. Advise females of reproductive potential and males (w. female partners) to use effective contraception during and for ≥1 week after the last dose. Pregnancy: exclude status prior to initiation. Nursing mothers: not recommended (during and for ≥1 week after the last dose).

QINLOCK Classification:

Tyrosine kinase inhibitor.

QINLOCK Interactions:

Potentiated by strong CYP3A4 inhibitors; monitor frequently. Antagonized by strong CYP3A4 inducers; avoid concomitant use. May be antagonized by moderate CYP3A4 inducers; avoid concomitant use; if unavoidable, increase dosing frequency (see Adult dose).

Adverse Reactions:

Alopecia, fatigue, nausea, abdominal pain, constipation, myalgia, diarrhea, decreased appetite, palmar-plantar erythrodysesthesia, vomiting; lab abnormalities (eg, increased lipase, decreased phosphate).

Generic Drug Availability:


How Supplied:


Pricing for QINLOCK

90 tablets of 50mg bottle (Qty: 1)
Appx. price $35816